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Abstract
There is a fast-growing literature on estimating optimal treatment
regimes based on randomized trials or observational studies under a
key identifying condition of no unmeasured confounding. Because
confounding by unmeasured factors cannot generally be ruled out
with certainty in observational studies or randomized trials subject to
noncompliance, we propose a general instrumental variable approach
to learning optimal treatment regimes under endogeneity. Specifi-
cally, we provide sufficient conditions for the identification of both
value function E[YD(L)] for a given regime D and optimal regime
arg maxD E[YD(L)] with the aid of a binary instrumental variable,
when no unmeasured confounding fails to hold. We also propose
novel multiply robust classification-based estimators. Furthermore,
we extend the proposed method to identify and estimate the opti-
mal treatment regime among those who would comply to the assigned
treatment under a standard monotonicity assumption. In this latter
case, we establish the somewhat surprising result that the complier op-
timal regime can be consistently estimated without directly collecting
compliance information and therefore without the complier average
treatment effect itself being identified. Our approach is illustrated via
extensive simulation studies and a data application on the effect of
child rearing on labor participation.
keywords Precision medicine, Optimal treatment regimes, Observational
studies, Instrumental variable, Unmeasured confounding
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1 Introduction
The primary goal of estimating an individualized treatment regime is to re-
cover a rule which assigns the treatment, among a set of possible treatments,
to each patient based on the individual’s characteristics. Optimal treat-
ment regimes have recently received a lot of attention in the statistical and
biomedical literatures. A prevailing strand of work in this literature has ap-
proached the optimal treatment problem through either Q-learning (Watkins
and Dayan, 1992; Chakraborty et al., 2010; Qian and Murphy, 2011; Laber
et al., 2014a; Schulte et al., 2014) or A-learning (Robins et al., 2000; Murphy,
2003; Robins, 2004; Shi et al., 2018). Recently, an alternative approach has
emerged from a classification perspective (Zhang et al., 2012a; Zhao et al.,
2012; Rubin and van der Laan, 2012), which has proven more robust to model
misspecification in some settings.
Recent explorations of optimal individual treatment regimes have con-
sidered a variety of data types, including within the context of standard
randomized experiments (Kosorok and Moodie, 2016; Kosorok and Laber,
2019; Tsiatis et al., 2019), but also observational studies (Athey and Wager,
2017; Kallus, 2018) and electronic health records (Wang et al., 2016; Wu
et al., 2018). There has also been work on estimating optimal individualized
treatment regimes with a somewhat different objective, such as quantiles for
outcome measure (Linn et al., 2015, 2017; Wang et al., 2018), tail control (Qi
et al., 2019a), and interpretability (Orellana et al., 2010; Laber and Zhao,
2015; Zhang et al., 2015).
A common assumption made in prior work on optimal treatment regimes
is that of no unmeasured confounding; an assumption which cannot be guar-
anteed in observational settings, nor in randomized experiments subject to
non-compliance. Without such an assumption, it is well-known that causal
effects, and in particular optimal treatment regimes cannot be identified non-
parametrically without an alternative assumption. The central controversy
of the unconfoundedness assumption is that one typically needs to collect
and appropriately account for a large number of relevant covariates in order
to make the assumption credible. The use of instrumental variables (IVs) is
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a well-known approach to estimate causal effects in observational studies or
randomized trials with noncompliance. An IV is defined as a pre-treatment
variable that is independent of all unmeasured confounders, and does not
have a direct causal effect on the outcome other than through the treatment.
In a double-blind, placebo-controlled, randomized trial, random assignment
is a common example of an ideal IV when patients fail to comply to assigned
treatment. A prominent IV approach in epidemiological studies, known as
Mendelian randomization studies, leverages genetics variants known to be
associated with the phenotype defining the exposure, in order to estimate
the causal effect of the phenotype on a health outcome. A well-known illus-
tration of the approach, takes fat mass and obesity-associated protein (FTO)
as a genetic IV to estimate a causal association between body mass index
(BMI) and depression (Walter et al., 2015).
Imbens and Angrist (1994); Angrist et al. (1996) proposed a formal coun-
terfactual based approach for binary treatment and IV, and established iden-
tification under a certain monotonicity assumption, of the so-called complier
average causal effect, i.e., the average treatment effect for the subset of the
population who would always comply to their assigned treatment. Building
on this original work, Abadie (2003); Tan (2006); Ogburn et al. (2015) have
developed various semiparametric methods for estimating complier average
treatment effects with appealing robustness and efficiency properties. The
average treatment effect generally differs from complier average causal ef-
fect and often is the causal effect of primary interest (Hernan and Robins,
2006; Aronow and Carnegie, 2013; Wang and Tchetgen Tchetgen, 2018). A
key contribution of Wang and Tchetgen Tchetgen (2018) was to formally
establish identification of the population average treatment effect under an
assumption of no common effect modifier by an unmeasured confounder, of
the additive effect of treatment on the outcome, and the additive effect of
the IV on treatment. Although it has developed a very rich literature on IV
methods for static regimes, to the best of our knowledge, no prior literature
exists on IV methods for optimal treatment regimes.
In this paper, we propose a number of IV learning methods for estimat-
ing optimal treatment regimes in case no unmeasured confounder assumption
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fails to hold. Specifically, we adapt and extend the weighted classification
perspective pioneered by Zhang et al. (2012a); Zhao et al. (2012); Rubin and
van der Laan (2012), by allowing for an endogenous treatment (i.e., con-
founded by unmeasured factors) which we account for by a novel use of an
IV. We take a classification perspective as it is now widely recognized to be
quite versatile for the purpose of estimating optimal treatment regimes, be-
cause of the large arsenal of robust classification methods and corresponding
off-the-shelf software that one can readily leverage.
The paper makes a number of contributions to both the IV and precision
medicine literatures. First, we provide sufficient conditions for identification
of an optimal treatment regime of a binary treatment subject to unmeasured
confounding, by leveraging a binary IV. Our identifying conditions are sim-
ilar to those of Wang and Tchetgen Tchetgen (2018) in the context of IV
estimation of the population average treatment effect. The proposed identi-
fication conditions give rise to IV estimators of the optimal treatment regime
without necessarily id-entifying the value function for a given regime. In
addition, we propose multiply robust classification-based estimators of the
optimal treatment regime provided that a subset of several posited models
indexing the observed data distribution is correctly specified.
We subsequently extend the proposed methods to identify and estimate
the optimal treatment regime among the subset of the population that would
always comply to their assigned treatment. A somewhat surprising theorem
establishes that under the standard identifying assumption of no defier (i.e.,
monotonicity of the effect of the IV on the treatment) one can in fact identify
an optimal complier treatment regime even when individuals’ realized treat-
ment values are not observed, and therefore the complier average treatment
effect itself is not identifiable. Our results therefore imply that in a random-
ized trial subject to non-compliance, it is possible to consistently infer an
optimal treatment regime for compliers even if, as often the case in practice,
investigators fail to collect adherence information on individual participants.
For instance, in a randomized trial with one-sided non-compliance (i.e., when
the placebo group cannot access the experimental treatment) whereby mono-
tonicity holds by design, one can obtain assumption-free inferences on who
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might benefit the most from the intervention, without necessarily knowing
who in the treatment arm adhered to the assigned treatment, and there-
fore one cannot recover the actual magnitude of the treatment effect among
compliers.
Our simulation studies confirm that the proposed inverse weighted and
multiply robust estimators perform well in realistic settings and in fact out-
perform existing methods in settings where unmeasured confounding is strong.
In particular, the proposed estimators have significantly higher empirical
value function, i.e., higher average potential outcome under the estimated
optimal treatment regime in the presence of unmeasured confounding. In
addition, the performance of the proposed estimators is comparable to that
of prior methods when there is no unmeasured confounding. We also apply
the proposed methods to a data application on the effect of child rearing on
labor participation.
The remainder of the article is organized as follows. In Section 2, we
present the mathematical framework for the use of IVs in estimating indi-
vidualized treatment regimes subject to unmeasured confounding. Section 3
develops two novel multiply robust classification-based estimators. Extensive
simulation studies are presented in Section 4. Section 5 describes application
of the proposed methods to mother’s labor participation. Next, we extend
the proposed methods to identify the optimal treatment regime among those
who would always comply to their assigned treatment in Section 6. The
article concludes with a discussion of future work in Section 7. Proofs and
additional results are provided in Appendix and Supplementary Material.
2 Methodology
We briefly introduce some general notation used throughout the paper. Let
Y denote the outcome of interest and A ∈ {+1,−1} be a binary treatment
indicator. Suppose that U is an unmeasured confounder (possibly vector-
value) of the effect of A on Y . Suppose also that one has observed a pre-
treatment binary instrumental variable Z ∈ {+1,−1}. Let L ∈ L denote
a set of fully observed pre-IV covariates, where L is a p dimensional vector
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space. Throughout we assume the complete data are independent and iden-
tically distributed realizations of (Y, L,A, U, Z); thus the observed data are
O = (Y, L,A, Z).
We wish to identify a treatment regime D, which is a mapping from
the patient-level covariate space L to the treatment space {+1,−1} that
maximizes the corresponding expected potential outcome for the population.
In other words, the goal is to estimate an optimal treatment regime, defined
as follows,
D∗(L) = sign{E(Y1 − Y−1|L)}, (1)
where Ya is a person’s potential outcome under an intervention that sets
treatment to value a, sign(x) = 1 if x > 0 and sign(x) = −1 if x < 0.
Throughout it is assumed that larger values of Y are more desirable.
Let YD(L) be the potential outcome under a hypothetical intervention that
assigns treatment according to regime D; this potential outcome is equiva-
lently expressed as
YD(L) ≡ Y1I{D(L) = 1}+ Y−1I{D(L) = −1}.
Throughout the paper, we make the following standard consistency and pos-
itivity assumptions: (i) For a given regime D, Y = YD(L) when A = D(L)
almost surely. That is, a person’s observed outcome matches his/her poten-
tial outcome under a given treatment regime when the realized treatment
matches his/her potential treatment assignment under the regime; (ii) We
assume that Pr(A = a|L) > 0 for a = ±1 almost surely, i.e., a person has an
opportunity to receive both treatments.
2.1 Optimal treatment regimes from a classification
perspective
Prior methods for estimating optimal treatment regimes have typically relied
on the following unconfoundedness assumption:
Assumption 1. (Unconfoundedness) Ya |= A|L.
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The assumption essentially rules out the existence of an unmeasured fac-
tor U that confounds the effects of A on Y upon conditioning on L. Such an
assumption is untestable without further restriction on the data-generating
mechanism and cannot generally be enforced outside of an ideal randomized
study.
It is straightforward to verify that under Assumption 1, one can identify
the counterfactual mean (known as the value function of regime D, (Qian
and Murphy, 2011)) E[YD(L)] for a given treatment regime D. Furthermore,
the optimal treatment regime in Equation (1) is identified from the observed
data by the following expression,
D∗(L) = sign{E(Y |L,A = 1)− E(Y |L,A = −1)}.
As established by Qian and Murphy (2011), learning the optimal individual-
ized treatment regime under unconfoundedness can alternatively be formu-
lated as
D∗ = arg max
D
EL
[
EYD [YD(L)|L]
]
= arg max
D
E
[
I{D(L) = A}Y
f(A|L)
]
, (2)
where I{·} is the indicator function. Qian and Murphy (2011); Zhang et al.
(2012b) proposed to directly maximize the value function over a restricted
set of functions.
Rather than maximizing the above value function, Zhao et al. (2012);
Zhang et al. (2012a) transformed the above problem into a formal, equivalent
weighted classification problem,
D∗ = arg min
D
E
[
Y
f(A|L)I{D(L) 6= A}
]
, (3)
with 0-1 loss function and weight Y/f(A|L). Zhao et al. (2012) addressed
the computational burden of formulation (3) by substituting the 0-1 loss with
the hinge loss and proposed to solve the optimization via support vector ma-
chines. The ensuing classification approach was shown to have appealing ro-
bustness properties, particularly in the context of a randomized study where
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no model assumption is needed.
Subsequent work has provided further extensions and refinements of the
classification perspective (Zhang et al., 2012a; Zhao et al., 2015a,b; Chen
et al., 2016; Zhou et al., 2017; Zhou and Kosorok, 2017; Cui et al., 2017; Zhu
et al., 2017; Liu et al., 2018; Zhang and Zhang, 2018). Notably, all prior
methods, whether classification-based or not, rely on the unconfoundedness
Assumption 1. As the assumption may not hold in observational studies or
randomized trials with non-compliance, in the next section, we introduce a
general framework for learning optimal treatment regimes under endogeneity
(i.e., unmeasured confounding).
2.2 Main identification results
In this section, we no longer rely on Assumption 1 and therefore allow for
unmeasured confounding. Instead, let Yz,a denote the potential outcome had,
possibly contrary to fact, a person’s IV and treatment value been set to z
and a, respectively. Suppose that the following assumption holds.
Assumption 2. (Latent unconfoundedness) Yz,a |= (Z,A)|L,U for z, a = ±1.
This assumption essentially states that together L and U would in prin-
ciple suffice to account for confounding of the joint effect of Z and A on
Y . Because U is not observed, we propose to account for it by making the
following standard IV assumptions:
Assumption 3. (IV Relevance) Z 6 |= A|L.
Assumption 4. (Exclusion Restriction) Yz,a = Ya for z, a = ±1 almost
surely.
Assumption 5. (IV independence) Z |= U |L.
Assumption 6. (IV positivity) There exists a constant M ∈ (0, 1/2) such
that M < f (Z = 1|L) < 1−M almost surely.
The first three conditions are well-known core IV conditions, while As-
sumption 6 is needed for nonparametric identification (Greenland, 2000; Her-
nan and Robins, 2006). Assumption 3 requires that the IV is associated with
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the treatment conditional on L. In a placebo controlled randomized trial with
non-compliance, this assumption will typically be satisfied for treatment as-
signment Z and treatment as taken A whenever more individuals take the
active treatment in the intervention arm than in the placebo arm. Note that
Assumption 3 does not rule out confounding of the Z-A association by an
unmeasured factor, however, if present, such factor must be independent of
U . We will refer to Z as a causal IV in case no such confounding is present.
Assumption 4 states that there can be no direct causal effect of Z on Y
not mediated by A. Assumption 5 ensures that the causal effect of Z on
Y is unconfounded given L. Figure 1 provides a graphical representation of
Assumptions 4 and 5 for a causal IV.
Z YA
L
U
Figure 1: Causal DAG with unmeasured confounding and a causal IV.
Under Assumptions 2-5, it is not possible to uniquely identify the value
function of a given regime D. Thus, directly optimizing the value function
does not appear possible even with a valid IV encoded in the DAG of Figure 1.
Nonetheless, it is possible to identify the treatment regime that maximizes
a lower bound of the value function (see Section F in the Supplementary
Material) without an additional assumption. In order to identify D∗, we
consider the following assumption.
Assumption 7. (No unmeasured common effect modifier)
Cov
{
δ˜(L,U), γ˜(L,U)|L
}
= 0,
almost surely, where δ˜(L,U) ≡ Pr(A = 1|Z = 1, L, U) − Pr(A = 1|Z =
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−1, L, U) and γ˜(L,U) ≡ E(Y1 − Y−1|L,U), respectively.
We also consider the following stronger condition.
Assumption 8. (Independent compliance type)
δ(L) ≡ Pr(A = 1|Z = 1, L)− Pr(A = 1|Z = −1, L) = δ˜(L,U) almost surely.
Assumption 8 essentially states that there is no additive interaction be-
tween Z and U in a model for the probability of being treated conditional
on L and U . As stated in Wang and Tchetgen Tchetgen (2018), this as-
sumption would hold if U was independent of a person’s compliance type.
Assumption 7 is implied by and therefore more general than Assumption A5
of Wang and Tchetgen Tchetgen (2018) which states that either δ˜(L,U) or
γ˜(L,U) does not depend on U (Wang, 2018). Clearly, Assumption 8 implies
Assumption 7 and therefore is more stringent. Now we are ready to state
our first identification result.
Theorem 2.1. Under Assumptions 2-7, arg maxD E[YD(L)] is nonparamet-
rically identified,
arg max
D
E[YD(L)] = arg maxD
E
[
ZI{A = D(L)}Y A
δ(L)f(Z|L)
]
. (4)
Furthermore, under Assumptions 2-6 and 8, for a given regime D,
E[YD(L)] = V(D) ≡ E
[
ZI{A = D(L)}Y A
δ(L)f(Z|L)
]
. (5)
Theorem 2.1 gives our main identification results, and states that the
optimal treatment regime is nonparametrically identified with a valid IV
satisfying Assumption 7, therefore extending prior identification of optimal
treatment regime to account for potential confounding by an unmeasured fac-
tor. The theorem further states that the functional V(D) nonparametrically
identifies the value function with a valid IV under the stronger Assump-
tion 8. Theorem 2.1 also serves as basis for the estimator proposed in the
next section.
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The following theorem shows that progress can be made towards identify-
ing an optimal treatment regime without necessarily using a person’s realized
treatment value A.
Theorem 2.2. Under Assumptions 2-7,
arg max
D
E[YD(L)] = arg maxD
E
[
I{Z = D(L)}Y
δ(L)f(Z|L)
]
. (6)
Remark 1. Interestingly, Theorem 2.2 implies that if it is known a priori
that the association between Z and A is positive conditional on L, i.e., δ(L) >
0, then it is possible to identify the optimal treatment regime even if one does
not directly observe the treatment variable A, by solving the optimization
problem arg maxD E[W˜ (L)I{Z = D(L)}Y/f(Z|L)] for any choice of weight
W˜ (L) > 0. Furthermore, in the event that external information is available
on δ(L), as would sometime be the case if a separate sample with data on
A, Z and L, solving the above optimization problem with W˜ (L) = 1/δ(L)
recovers Equation (6).
2.3 An IV approach to weighted learning
In this section, motivated by Theorem 2.1 and 2.2, we propose two classification-
based estimators. To further motivate our classification-based approach, note
that optimization tasks (4) and (6) are equivalent to
arg min
D
E
[
W (1)I{A 6= D(L)}] , (7)
arg min
D
E
[
W (2)I{Z 6= D(L)}] , (8)
respectively, where
W (1) =
AZY
δ(L)f(Z|L) , W
(2) =
Y
δ(L)f(Z|L) .
Hereafter, we focus primarily on Equation (7) to develop our estimator al-
though our results readily extend to Equation (8). The idea behind our
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estimator is similar in spirit to Zhang et al. (2012a); Zhao et al. (2012); Ru-
bin and van der Laan (2012); Zhang and Zhang (2018) in that this alternative
formulation of the optimization task may be interpreted as a classification
problem in which one aims to classify A using L with misclassification error
given by the weighted outcome W . Because the weight may not be positive
(e.g., for samples with A 6= Z even if Y/δ(L) > 0), in order to remedy this
difficulty, we further modify the weights by adopting the approach of Liu
et al. (2016) who leverage the following equality
arg min
D
E [|W |I{sign(W )A 6= D(L)}] = arg min
D
E [WI{A 6= D(L)}] . (9)
We follow Zhao et al. (2012) and proceed with convex optimization via the
use of hinge loss function. Furthermore, we penalize the complexity of the
decision function to avoid overfitting. Thus, we propose to estimate the
optimal treatment regime by minimizing the following regularized objective
function,
1
n
n∑
i=1
|Wi|φ
(
sign(Wi)Aig(Li)
)
+
λ
2
||g||2, (10)
where φ is the hinge loss function, g encodes the decision function within a
specific class, and λ is a tuning parameter. The weight Wi is unknown and
therefore estimated from the data in a first step, and then substituted in
(10).
We refer to Zhao et al. (2012) for solving this optimization with linear
and nonlinear decision rules. Note that variable selection techniques can be
incorporated in the proposed approach when the dimension of covariates is
high. For example, the variable selection techniques developed in Zhao et al.
(2012); Zhou et al. (2017) can readily be adopted here, in which l2 penalty
is replaced with the elastic-net penalty (Zou and Hastie, 2005). The Fisher
consistency, excess risk bound and universal consistency of the estimated
treatment regime is shown in the Supplementary Material. The proof is akin
to Zhao et al. (2012); Zhou and Kosorok (2017).
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Algorithm 1: Pseudo algorithm for the proposed weighted learning
Input: {(Yi, Li, Ai, Zi), i = 1, . . . , n};
1 Obtain estimates of δ(L) and f(Z|L), denoted δ̂(L) and f̂(Z|L),
respectively. For instance, one may estimate the density of Z by
fitting a logistic regression on a finite vector of known functions of L,
and estimate δ(L) by fitting a logistic regression of A on a finite
vector of known functions of (L,Z);
2 Compute
Ŵ
(1)
i =
AiZiYi
δ̂(Li)f̂(Zi|Li)
, Ŵ
(2)
i =
Yi
δ̂(Li)f̂(Zi|Li)
, i = 1, . . . , n;
3 Solve the following optimization
min
g
1
n
n∑
i=1
|Ŵ (1)i |φ
(
sign(Ŵ
(1)
i
)
Aig(Li)) +
λ
2
||g||2,
min
g
1
n
n∑
i=1
|Ŵ (2)i |φ
(
sign(Ŵ
(2)
i
)
Zig(Li)) +
λ
2
||g||2,
and obtain the estimated decision function ĝ;
4 Return D̂ = sign(ĝ).
3 Multiply robust classification-based estima-
tors
We characterize the efficient influence function of V(D) under Assumptions
2-6 and 8 as shown in Theorem H.1 in the Supplementary Material. In
principle, one could estimate the optimal treatment regime which maximizes
E[YD(L)] over a class of parametric models of optimal treatment regime, as
proposed by Zhang et al. (2012b) in case of unconfoundedness. However, this
kind of approach may restrict the treatment regime to a relatively small set of
possible functions and therefore may be suboptimal. An alternative approach
is to develop a multiply robust classification-based estimator (Zhang et al.,
2012a; Zhao et al., 2012; Rubin and van der Laan, 2012; Zhang and Zhang,
2018) of optimal treatment regime as described in the following.
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We denote the conditional average treatment effect as
∆(L) = E(Y1 − Y−1|L).
Note that in order to learn the optimal treatment regime, we essentially need
to minimize the following weighted classification error with respect to regime
D.
E[A∆(L)I{A 6= D(L)}] or E[Z∆(L)I{Z 6= D(L)}]. (11)
Because ∆(L) is not observed and must be estimated. The choice of
statistic
∆˜(L) =
ZY
δ(L)f(Z|L) ,
substituted in Equation (11) recovers the estimators which we described in
Section 2.
Consider the following multiply robust statistic proposed in Wang and
Tchetgen Tchetgen (2018) and define ∆˜MR(L) as
∆˜MR(L) =
Z
δ(L)f(Z|L)
[
Y − A∆(L)− E[Y |Z = −1, L] + ∆(L)E[A|Z = −1, L]
]
+ ∆(L)
to obtain the following multiply robust weights
Ŵ
(1)
MR =
[
ZA
δ(L, β̂)f̂(Z|L)
{
Y − A∆(L, θ̂)
− Ê[Y |Z = −1, L] + ∆(L, θ̂)Ê[A|Z = −1, L]
}
+ A∆(L, θ̂)
]
,
and
Ŵ
(2)
MR =
[
1
δ(L, β̂)f̂(Z|L)
{
Y − A∆(L, θ̂)
− Ê[Y |Z = −1, L] + ∆(L, θ̂)Ê[A|Z = −1, L]
}
+ Z∆(L, θ̂)
]
,
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respectively, where δ(L, β̂) and ∆(L, θ̂) are doubly robust estimators of δ(L)
and ∆(L), and other nuisance estimators are estimated by maximum likeli-
hood estimation. Under standard regularity conditions (White, 1982), δ(L, β̂),
∆(L, θ̂), f̂(Z|L), Ê(Y |L,Z = −1), Ê(A|L,Z = −1) converge in probability
to δ(L, β∗), ∆(L, θ∗), f ∗(Z|L), E∗(Y |L,Z = −1), E∗(A|L,Z = −1). Al-
though not pursued in the current paper, it is also possible to use infinite-
dimensional models to estimate these nuisance parameters. In Theorem 3.1,
we show that
∆
∗(1)
D = E
[
W
∗(1)
MR I(D(L) = A)
]
and ∆
∗(2)
D = E
[
W
∗(2)
MR I(D(L) = Z)
]
are multiply robust in the sense of maximizing the value function in the union
model of the following models:
M′1: models for f(Z|L) and δ(L) are correct;
M′2: models for f(Z|L) and ∆(L) are correct;
M′3: models for ∆(L), E[Y |Z = −1, L], δ(L), E[A|Z = −1, L] are correct;
where the weights are
W
∗(1)
MR =
[
ZA
δ(L, β∗)f(Z|L, ν∗)
{
Y − A∆(L, θ∗)− E∗(Y |L,Z = −1)
+ ∆(L, θ∗)E∗(A|L,Z = −1)
}
+ A∆(L, θ∗)
]
,
and
W
∗(2)
MR =
[
1
δ(L, β∗)f(Z|L, ν∗)
{
Y − A∆(L, θ∗)− E∗(Y |L,Z = −1)
+ ∆(L, θ∗)E∗(A|L,Z = −1)
}
+ Z∆(L, θ∗)
]
.
Theorem 3.1. Under Assumptions 2-7 and standard regularity conditions,
we have that
arg max
D
∆
∗(1)
D = arg maxD
∆
∗(2)
D = arg maxD
E[∆(L)D(L)],
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under the union model M′union =M′1 ∪M′2 ∪M′3.
Consequently, following the theoretical results established in Section G in
the Supplementary Material, the risk of the estimated treatment regime D̂
converges to the Bayes risk in probability.
4 Simulation experiments
In this section, we report extensive simulation studies comparing the pro-
posed estimators to outcome weighted learning (Zhao et al., 2012) and resid-
ual weighted learning (Zhou et al., 2017), which are in principle valid only
under unconfounded treatment.
4.1 Simulation settings
We generated L from a uniform distribution on [−1, 1]5. Treatment A was
generated under a logistic regression with success probability,
Pr(A = 1|L,Z, U) = expit{2L(1) + 2.5Z − 0.5U},
with Z Bernoulli event with probability 1/2, and U from a bridge distribution
with parameter φ = 1/2. By a theorem of Wang and Louis (2003), the above
data generating mechanism ensures that there exists a vector α such that
logit{Pr(A = 1|L,Z)} = αT (1, L, Z), so that upon marginalizing over U the
model for f(A|L,Z) remains a logistic regression. Additional simulations
are conducted in the Supplementary Material (Tables 4-7) to illustrate how
the strength of the instruments affects the variance of the estimated value
functions.
The outcome Y was generated differently in each scenario as described
below. The sample size was 500 for each scenario. We repeated the simulation
500 times. A large independent test set with 10000 subjects was used to
evaluate the performance of different methods. Additional simulation results
with sample sizes 250 and 1000 are shown in Tables 8-11 in the Supplementary
Material.
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The proposed methods were implemented according to Algorithm 1 with
δ̂(L) = f̂(A|L,Z = 1) − f̂(A|L,Z = −1) and f̂(Z|L), where f̂(A|L,Z) and
f̂(Z|L) were estimated from logistic regression models. Outcome weighted
learning and residual weighted learning likewise used f̂(A|L,Z) for f(A|L,Z).
In addition, we implemented multiply robust weights with correctly specified
M ′1 but incorrect models for M
′
2 and M
′
3 to better understand the sensitivity
of the proposed methods to misspecified nuisance models. In particular,
E[Y |L,Z] was estimated by a linear regression, denoted by Ê[Y |L,Z], and
∆(L) was estimated by ∆̂(L) = ∆̂Y (L)/δ̂(L), where ∆̂Y (L) = Ê[Y |L,Z =
1]−Ê[Y |L,Z = −1]. Furthermore, Ê[A|Z = −1, L] and δ̂(L) were estimated
by logistic regressions as specified above. Both linear and Gaussian kernels
were considered for all methods. We applied cross-validation for choosing
tuning parameters by searching over a pre-specified finite set following Zhao
et al. (2012).
We considered the following four scenarios for the outcome model, with
both linear and non-linear outcome models:
(1) Y = h(L) + q(L)A+ ,
(2) Y = h(L) + q(L)A+ 0.5U + ,
(3) Y = exp{h(L) + q(L)A}+ ,
(4) Y = exp{h(L) + q(L)A}+ U + ,
where the error term  followed the standard normal distribution, and
h(L) = (0.5 + 0.5L(1) + 0.8L(2) + 0.3L(3) − 0.5L(4) + 0.7L(5)),
q(L) = (0.2− 0.6L(1) − 0.8L(2)).
Scenarios 1 and 3 were considered in Zhou and Kosorok (2017). Settings 2
and 4 are modifications of 1 and 3 by adding unmeasured confounding.
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4.2 Numerical results
Table 1 reports the mean and standard deviation of value functions evaluated
at estimated optimal regimes in test samples. Table 2 reports the mean
and standard deviation of correct classification rates in test samples. It is
interesting to note that, by leveraging Equation (9), the proposed estimators
with W = W (1) and W = W (2) give the same estimated treatment regime,
so do the multiply robust estimators with W
(1)
MR and W
(2)
MR.
In scenario 1, as unconfoundedness assumption 1 holds, it is not surpris-
ing that all methods perform similarly. In scenario 2, where U is present, the
treatment assignment and the outcome are confounded. Outcome weighted
learning and residual weighted learning in this case fail to find an optimal
regime. Our estimated treatment regime performs much better for both lin-
ear and Gaussian kernels. In scenarios 3 and 4, we again observe a consistent
pattern that the proposed method performs much better in the presence of
unmeasured confounding. Furthermore, in almost all scenarios, the multi-
ply robust estimator improves upon inverse weighted estimator and residual
weighted learning improves upon outcome weighted learning.
Table 1: Simulation results: Mean ×10−2 (sd ×10−2) of value functions
Kernel OWL RWL IV-IW IV-MR
1
Linear 96.0 (2.9) 97.3 (1.8) 95.6 (4.8) 96.9 (2.9)
Gaussian 87.6 (7.5) 95.4 (3.1) 89.3 (9.0) 93.4 (5.7)
2
Linear 35.9 (17.3) 37.9 (18.4) 91.5 (7.6) 92.3 (7.2)
Gaussian 61.2 (9.9) 61.4 (10.2) 81.8 (11.3) 85.4 (9.7)
3
Linear 356.5 (4.4) 359.4 (2.5) 358.5 (3.4) 358.9 (3.1)
Gaussian 297.0 (33.0) 356.6 (4.4) 315.8 (34.6) 354.7 (8.4)
4
Linear 275.1 (4.6) 275.8 (6.6) 349.1 (12.1) 349.8 (10.1)
Gaussian 280.4 (13.2) 298.2 (14.0) 308.3 (33.8) 331.2 (23.0)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR. The empirical opti-
mal value functions are 0.998, 0.995, 3.636, 3.630 for four scenarios, respec-
tively.
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Table 2: Simulation results: Mean ×10−2 (sd ×10−2) of correct classification
rates
Kernel OWL RWL IV-IW IV-MR
1
Linear 88.0 (4.2) 90.2 (3.3) 87.8 (5.6) 89.7 (4.0)
Gaussian 79.3 (7.5) 87.5 (4.1) 81.4 (8.5) 85.4 (6.0)
2
Linear 42.0 (10.0) 42.9 (10.3) 83.0 (7.9) 84.0 (7.6)
Gaussian 57.1 (6.6) 57.5 (6.9) 74.5 (9.5) 77.5 (8.6)
3
Linear 88.7 (3.6) 90.0 (3.7) 90.3 (3.4) 89.9 (3.2)
Gaussian 71.1 (9.8) 87.9 (4.6) 75.7 (11.7) 88.0 (5.2)
4
Linear 37.3 (2.0) 37.5 (2.7) 83.1 (7.4) 83.2 (6.7)
Gaussian 44.8 (6.5) 48.4 (7.7) 69.0 (11.3) 74.8 (10.2)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR.
As can be seen from Tables 4-7 in the Supplementary Material, a higher
compliance rate generally leads to a lower variance of the estimated regime
in terms of both value functions and correct classification rates. In Tables 8-
11, the observed patterns are consistent across different sample sizes, and as
sample size increases, the proposed methods have higher prediction accuracy.
5 The effect of child rearing on labor partic-
ipation
In this section, we follow Angrist and Evans (1998) and study a sample of
married mothers with two or more children from 1980 census data. The data
entail a publicly available sample from the U.S. 1980 census of married and
unmarried mothers. Angrist and Evans (1998) estimated the local average
treatment effect of having a third child among mothers with at least two
children. Athey et al. (2019) identified a conditional local average treatment
effect given several covariates.
We seek to provide a personalized recommendation on whether or not a
woman should plan to have a third child without compromising her ability to
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participate in the labor market. Therefore, we wish to discover the optimal
regime for deciding to have three or more children in order to maximize the
probability of remaining in the labor market. We included the following five
covariates considered in (Athey et al., 2019): the mother’s age at the birth of
her first child, her age at census time, her years of education and her race, as
well as the father’s income. The outcome Y was whether or not the mother
worked in the year preceding the census. The treatment A denoted whether
the mother had three or more children at census time, and the instrument Z
was whether or not the mother’s first two children were of the same sex.
In order to draw comparison between the various methods, we randomly
selected 500 subjects as training set and 5000 subjects as test set from the
original dataset including 561,459 subjects. This procedure was repeated 100
times. We performed the analysis on the training dataset, and obtained the
estimated optimal treatment regimes from the three methods evaluated in
the previous section. The nuisance parameters were estimated as described
in Section 4 except for E[Y |L,Z] which we modeled as a logistic regression
because the outcome was binary. Tuning parameters were selected in the
same way as Section 4. Empirical values of estimated treatment regime D̂
were evaluated with
V =
1
n
n∑
i=1
Ŵ
(1)
i I{Ai = D̂(Li)},
where Ŵ
(1)
i was estimated by logistic regression according to Algorithm 1
using test dataset. A larger empirical value may be interpreted as a better
performance.
Results are presented in Table 3. Both proposed methods have higher
values for linear and Gaussian kernels, and Monte Carlo standard errors are
comparable across all methods. In addition, compared to outcome weighted
learning, residual weighted learning has lower mean and higher variance of
value functions for both linear and gaussian kernels, which is less likely to
happen if no unmeasured confounding assumption holds. A possible reason
is that unmeasured confounding causes inaccurate estimation of outcome
weighted learning and residual weighted learning. We selected 500 subjects
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and investigated the estimated linear decision rules. Intuitively, one might
expect that having a third child would generally reduce a mother’s labor
participation even if the effects are heterogeneous. However, half of the co-
efficients of the estimated decision functions for outcome weighted learning
and residual weighted learning appear to be positive. Thus, the correspond-
ing decision rule might be incorrectly recommending women to have a third
child which may in fact reduce their labor participation. In contrast, most of
the coefficients of the estimated decision function for both proposed methods
are negative and therefore, the proposed methods seem to recommend the
expected optimal policy.
Table 3: Real data application: Mean ×10−2 (sd ×10−2) of V
Kernel OWL RWL IV-IW IV-MR
Linear 60.5 (21.6) 60.8 (25.1) 61.2 (24.3) 63.7 (24.1)
Gaussian 64.5 (24.3) 63.8 (25.1) 64.6 (22.3) 65.4 (23.7)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR.
6 Optimal complier treatment regimes
We extend results developed in Section 2 to target a complier optimal treat-
ment regime, i.e., a treatment regime that would optimize the potential out-
come among compliers:
D†(L) = sign(E[Y1 − Y−1|A1 > A−1, L]),
where Az denotes the potential treatment under an intervention that sets the
IV Z to z. We define compliers’ value function,
Vc(D) =
{
E
[
I{D(L) = 1}E[Y1|A1 > A−1, L] + I{D(L) = −1}E[Y−1|A1 > A−1, L]
∣∣∣∣A1 > A−1]} .
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Thus, the complier optimal treatment regime can be formulated as
D† = arg max
D
Vc(D).
In order to identify the complier optimal treatment regime, we make the
following well-known assumption.
Assumption 9. (Monotonicity) Pr(A1 ≥ A−1) = 1.
Assumption 9 essentially rules out the existence of defiers in the popu-
lation, i.e., with A1 < A−1. Furthermore, we assume Z to be a causal IV
(Hernan and Robins, 2006), i.e., the causal effects of the IV on the treatment
and outcome are unconfounded given L in the following sense.
Assumption 10. (Causal IV) Z |= (Az, Yz,a)|L for z, a = ±1.
Then we have the following two identification results analogous to Theo-
rem 2.1 and 2.2, respectively.
Theorem 6.1. Under Assumptions 3-4, 6, and 9-10, the compliers’ value
function is nonparametrically identified:
Vc(D) = E
[
ZAY I{A = D(L)}
{Pr(A = 1|Z = 1)− Pr(A = 1|Z = −1)}f(Z|L)
]
.
Therefore, the complier optimal treatment regime is given by
arg max
D
E
[
ZAY I{A = D(L)}
f(Z|L)
]
.
Theorem 6.2. Under Assumptions 3-4, 6, and 9-10, the complier optimal
treatment regime is nonparametrically identified,
arg max
D
Vc(D) = arg maxD E
[
Y I(Z = D(L))
f(Z|L)
]
. (12)
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Remark 2. Theorem 6.2 is somewhat surprising, as it suggests that one
can in fact identify the optimal treatment regime for those who would always
comply to their assigned treatment without observing their realized treatment
values. Intuition about this result is gained upon noting that under mono-
tonicity, the effect of Z on Y within levels of L is proportional to the causal
effect of A on Y among compliers within levels of L, where the proportionality
constant within levels of L is the (nonnegative) additive causal effect of Z on
A. Consequently, under monotonicity assumption, optimizing the value func-
tion E[E(Y |Z = D(L), L)] with respect to the treatment assignment policy
(i.e., applying standard outcome weighted learning w.r.t. Z), is equivalent to
optimizing the value function among compliers with respect to the treatment
arg maxE(YD(L)|A1 > A−1), a task which can therefore be accomplished with-
out directly observing the treatment variable. Thus, it is possible to learn who
might benefit most from the intervention even when one does not observe A
and therefore cannot identify the complier average treatment effect.
Remark 3. Typically, the first step in IV analyses is to assess the strength
of the instrument by calculating the compliance rate. The strength of an IV is
directly related to the performance of the corresponding estimator. When we
do not observe the treatment, there is no way to guarantee that the IV and
the treatment are strongly associated, in which case weak IV problem can-
not necessarily be assessed (Bound et al., 1995; Small and Rosenbaum, 2008;
Baiocchi et al., 2010, 2014; Ertefaie et al., 2018). In well designed random-
ized experiments subject to non-compliance, although not perfect, compliance
nevertheless typically remains relatively high (i.e., ≥ 80%).
Empirical versions of equations in Theorem 6.1 and 6.2 give rise to es-
timators of value function and optimal treatment regime, respectively. Fur-
thermore, it is relatively straightforward to show that results analogous to
Section G in the Supplementary Material also hold for the complier optimal
treatment regime.
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7 Discussion
In this paper, we have proposed a general instrumental variable approach to
learning optimal treatment regimes under endogeneity. To our knowledge,
this is the first result for estimating optimal regime when no unmeasured
confounding fails to hold. Specifically, we provided sufficient conditions for
the identification of both value function E[YD(L)] for a given regime D and
optimal regime arg maxD E[YD(L)] with the aid of a binary IV. We established
consistency of the proposed weighted estimators. We also extended the pro-
posed method to identify and estimate the optimal treatment regime among
compliers under monotonicity. In the latter case, we established the some-
what surprising result that the complier optimal treatment regime can be
consistently estimated without accessing compliance information. Further-
more, we proposed novel semiparametric locally efficient and multiply robust
estimators. Our approach was illustrated via extensive simulation studies
and a real data application.
The proposed methods may be improved or extended in several directions.
Sometimes the values of instruments are unknown and must be estimated
using the data (Baiocchi et al., 2014; Ertefaie et al., 2018), e.g., preference-
based IVs (Brookhart and Schneeweiss, 2007). Understanding the implica-
tion for inference of empirically defining IV is a fruitful avenue of future
research. Moreover, as mentioned in Remark 3, it is known that weak IVs
can be problematic (Bound et al., 1995; Small and Rosenbaum, 2008; Baioc-
chi et al., 2010, 2014; Ertefaie et al., 2018). It may be possible to estimate
the optimal treatment regime by empirically building stronger instruments
(Baiocchi et al., 2010; Zubizarreta et al., 2013; Baiocchi et al., 2014; Ertefaie
et al., 2018).
The proposed methods can also be modified in case of a censored survival
outcome by accounting for possibly dependent censoring, thus providing ex-
tensions to Zhao et al. (2015b); Cui et al. (2017) to leverage an IV. In addi-
tion, trials with multiple treatment arms occur frequently. Thus a potential
extension of our method is in the direction of multicategory classification
(Sun et al., 2017; Zhou et al., 2018; Qi et al., 2019b). Furthermore, personal-
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ized dose finding (Chen et al., 2016; Zhou and Zhu, 2018) with unmeasured
confounding is also of interest. Finally, it would be of interest to extend our
method to mobile health dynamic treatment regimes where a sequence of
decision rules need to be learned under endogeneity (Robins, 2004; Zhang
et al., 2013; Laber et al., 2014b; Zhao et al., 2015a; Luckett et al., 2019).
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Appendix
A Proof of Theorem 2.1
Proof. We first note that
E
[
ZI{A = D(L)}Y A
δ(L)f(Z|L)
]
=E
[∑
a
ZI{A = a}I{D(L) = a}Yaa
δ(L)f(Z|L)
]
=E
[∑
a
ZI{A = a}I{D(L) = a}E[Ya|L,U ]a
δ(L)f(Z|L)
]
=E
[∑
a
Z Pr(A = a|L,U, Z)I{D(L) = a}E[Ya|L,U ]a
δ(L)f(Z|L)
]
=E
[
Pr(A = 1|L,U, Z = 1)I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
−E
[
Pr(A = 1|L,U, Z = −1)I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
−E
[
Pr(A = −1|L,U, Z = 1)I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
+E
[
Pr(A = −1|L,U, Z = −1)I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
=E
[
[Pr(A = 1|L,U, Z = 1)− Pr(A = 1|L,U, Z = −1)] I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
+E
[
[Pr(A = 1|L,U, Z = 1)− Pr(A = 1|L,U, Z = −1)] I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
≡(I).
In order to maximize counterfactual mean E[YD(L)], we only need As-
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sumption 7 rather than Assumption 8. To see this, note that
E[Y1|L,U ]I{D(L) = 1}+ E[Y−1|L,U ]I{D(L) = −1}
=(E[Y1|L,U ]− E[Y−1|L,U ])I{D(L) = 1}+ E[Y−1|L,U ]I{D(L) = 1}+ E[Y−1|L,U ]I{D(L) = −1}
=(E[Y1|L,U ]− E[Y−1|L,U ])I{D(L) = 1}+ E[Y−1|L,U ].
By Assumption 7, we further have that
(I) =E
[
Pr(A = 1|U,L, Z = 1)− Pr(A = 1|U,L, Z = −1)
δ(L)
{
(E[Y1|L,U ]− E[Y−1|L,U ])I{D(L) = 1}+ E[Y−1|L,U ]
}−1
]
=E
{
(E[Y1|L,U ]− E[Y−1|L,U ]) I{D(L) = 1}
+
Pr(A = 1|U,L, Z = 1)− Pr(A = 1|U,L, Z = −1)
δ(L)
E[Y−1|L,U ]
}
=E
[
E(Y1 − Y−1|L)I{D(L) = 1}
]
+ E
{
[Pr(A = 1|U,L, Z = 1)− Pr(A = 1|U,L, Z = −1)]E[Y−1|L,U ]
δ(L)
}
=E
[
E(Y1 − Y−1|L)I{D(L) = 1}
]
+ E[κ(L,U)],
where the second term E[κ(L,U)] doesn’t depend on D. Recall that
arg max
D
E[YD(L)] = arg maxD
E[E(Y1 − Y−1|L)I{D(L) = 1}],
so maximizing (I) is equivalent to maximize E[YD(L)].
Furthermore, by Assumption 8,
(I) =E (I{D(L) = 1}E[Y1|L,U ] + I{D(L) = −1}E[Y−1|L,U ])
=E[YD(L)].
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B Proof of Theorem 2.2
Proof.
E
[
I{D(L) = Z}Y
δ(L)f(Z|L)
]
=E
[∑
a
I{D(L) = Z}YaI{A = a}
δ(L)f(Z|L)
]
=E
[∑
a
I{D(L) = Z}E[Ya|L,U ] Pr(A = a|L,U, Z)
δ(L)f(Z|L)
]
=E
[
Pr(A = 1|L,U, Z = 1)I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
+E
[
Pr(A = 1|L,U, Z = −1)I{D(L) = −1}E[Y1|L,U ]
δ(L)
]
+E
[
Pr(A = −1|L,U, Z = 1)I{D(L) = 1}E[Y−1|L,U ]
δ(L)
]
+E
[
Pr(A = −1|L,U, Z = −1)I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
=E
[
[Pr(A = 1|L,U, Z = 1)− Pr(A = 1|L,U, Z = −1)] I{D(L) = 1}E[Y1|L,U ]
δ(L)
]
+E
[
[Pr(A = 1|L,U, Z = 1)− Pr(A = 1|L,U, Z = −1)] I{D(L) = −1}E[Y−1|L,U ]
δ(L)
]
+E
[
Pr(A = 1|L,U, Z = −1)E[Y1|L,U ]
δ(L)
]
+E
[
Pr(A = −1|L,U, Z = −1)E[Y−1|L,U ]
δ(L)
]
=E
(
E[Y1 − Y−1|L]I{D(L) = 1}
)
+ E[κ(L,U)],
where
κ(L,U) =
[Pr(A = 1|U,L, Z = 1)− Pr(A = 1|U,L, Z = −1)]E[Y−1|L,U ]
δ(L)
+
Pr(A = 1|L,U, Z = −1)E[Y1|L,U ] + Pr(A = −1|L,U, Z = −1)E[Y−1|L,U ]
δ(L)
.
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C Proof of Theorem 6.1
Proof. We have the following equality
E
[
I{D(L) = A}Y AZ
f(Z|L)
]
=E
[∑
a
I{D(L) = A}YaI{A = a}aZ
f(Z|L)
]
=E
[∑
z
∑
a
I{D(L) = a}YaI{Az = a}I{Z = z}az
f(Z|L)
]
=E
[∑
z
∑
a
I{D(L) = a}YaazI{Az = a}
]
=E [I{A1 = 1}I{D(L) = 1}Y1]− E [I{A−1 = 1}I{D(L) = 1}Y1]
−E [I{A1 = −1}I{D(L) = −1}Y−1] + E [I{A−1 = −1}I{D(L) = −1}Y−1]
=E [I{A1 = 1}I{D(L) = 1}Y1]− E [I{A−1 = 1}I{D(L) = 1}Y1]
+E [I{A1 = −1}I{D(L) = 1}Y−1]− E [I{A−1 = −1}I{D(L) = 1}Y−1]
−E [I{A1 = −1}Y−1] + E [I{A−1 = −1}Y−1]
=E
[
I{D(L) = 1}Y1[I{A1 = 1} − I{A−1 = 1}]
]
+E
[
I{D(L) = 1}Y−1[I{A1 = −1} − I{A−1 = −1}]
]
+ κ
=E
[
I{D(L) = 1}E[Y1 − Y−1|A1 > A−1, L]
[
I{A1 = 1} − I{A−1 = 1}
]]
+ κ
=E
[
I{D(L) = 1}E[Y1 − Y−1|A1 > A−1, L]
∣∣∣∣A1 > A−1]Pr(A1 > A−1) + κ,
where
κ = −E [I{A1 = −1}Y−1] + E [I{A−1 = −1}Y−1]
=E [[I{A1 = 1} − I{A−1 = 1}]Y−1]
=E[Y−1|A1 > A−1] Pr(A1 > A−1).
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Thus,
E
[
ZAY I{A = D(L)}
f(Z|L)
]
identifies compliers’ value fnuction Vc(D), i.e.,{
E
[
I{D(L) = 1}E[Y1|A1 > A−1, L] + I{D(L) = −1}E[Y−1|A1 > A−1, L]
∣∣∣∣A1 > A−1]}Pr(A1 > A−1).
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D Proof of Theorem 6.2
Proof. We have the following equality
E
[
I{D(L) = Z}Y
f(Z|L)
]
=E
[∑
a
I{D(L) = Z}YaI{A = a}
f(Z|L)
]
=E
[∑
z
∑
a
I{D(L) = z}YaI{Az = a}I{Z = z}
f(Z|L)
]
=E
[∑
z
∑
a
I{D(L) = z}YaI{Az = a}
]
=E [I{A1 = 1}I{D(L) = 1}Y1] + E [I{A−1 = 1}I{D(L) = −1}Y1]
+E [I{A1 = −1}I{D(L) = 1}Y−1] + E [I{A−1 = −1}I{D(L) = −1}Y−1]
=E [I{A1 = 1}I{D(L) = 1}Y1]− E [I{A−1 = 1}I{D(L) = 1}Y1]
+E [I{A1 = −1}I{D(L) = 1}Y−1]− E [I{A−1 = −1}I{D(L) = 1}Y−1]
+E [I{A−1 = 1}Y1] + E [I{A−1 = −1}Y−1]
=E
[
I{D(L) = 1}Y1[I{A1 = 1} − I{A−1 = 1}]
]
+E
[
I{D(L) = 1}Y−1[I{A1 = −1} − I{A−1 = −1}]
]
+ κ
=E
[
I{D(L) = 1}E[Y1 − Y−1|A1 > A−1, L]
[
I{A1 = 1} − I{A−1 = 1}
]]
+ κ
=E
[
I{D(L) = 1}E[Y1 − Y−1|A1 > A−1, L]
∣∣A1 > A−1]Pr(A1 > A−1) + κ,
where κ = E [I{A−1 = 1}Y1] + E [I{A−1 = −1}Y−1] does not depend on D.
This completes our proof.
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E Proof of Theorem 3.1
Proof. For ∆
∗(1)
D , we have that
1
2
E
[
W
∗(1)
MR I{A = D(L)}
]
=E
[
W
∗(1)
MR [2I{A = D(L)} − 1]
]
+ E
[
W
∗(1)
MR
]
=E
[
W
∗(1)
MRAD(L)
]
+ E
[
W
∗(1)
MR
]
=E
[{
Z
δ(L, β∗)f ∗(Z|L)
[
Y − A∆(L, θ∗)− E∗[Y |Z = −1, L]+
∆(L, θ∗)E∗[A|Z = −1, L]
]
+ ∆(L, θ∗)
}
D(L)
]
+ E
[
W
∗(1)
MR
]
=E
[
∆(L)D(L)
]
+ E
[
W
∗(1)
MR
]
,
where the last equality holds under any of M′1, M′2, or M′3, and the proof
follows a similar argument of Theorem 6 in Wang and Tchetgen Tchetgen
(2018).
For ∆
∗(2)
D , we have that
1
2
E
[
W
∗(2)
MR I{Z = D(L)}
]
=E
[
W
∗(2)
MR [2I{Z = D(L)} − 1]
]
+ E
[
W
∗(2)
MR
]
=E
[
W
∗(2)
MRZD(L)
]
+ E
[
W
∗(2)
MR
]
=E
[{
Z
δ(L, β∗)f ∗(Z|L)
[
Y − A∆(L, θ∗)− E∗[Y |Z = −1, L]+
∆(L, θ∗)E∗[A|Z = −1, L]
]
+ ∆(L, θ∗)
}
D(L)
]
+ E
[
W
∗(2)
MR
]
=E
[
∆(L)D(L)
]
+ E
[
W
∗(2)
MR
]
,
where the last equality holds under any ofM′1,M′2, orM′3. This completes
our proof.
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Supplementary Material
F Lower and upper bound of V(D)
Lemma F.1. Provided that Z is a valid causal IV (as defined by Balke and
Pearl (1997)) and outcome Y is binary, we have the following lower and
upper bounds of the value function,
E [L (L) I {D(L) = 1}] + E [L−1 (L)] ≤ E
(
YD(L)
)
,
E [U (L) I {D(L) = 1}] + E [U−1 (L)] ≥ E
(
YD(L)
)
,
where
L (l) = max

p−1,−1,−1,l + p1,1,1,l − 1
p−1,−1,1,l + p1,1,1,l − 1
p1,1,−1,l + p−1,−1,1,l − 1
p−1,−1,−1,l + p1,1,−1,l − 1
2p−1,−1,−1,l + p1,1,−1,l + p1,−1,1,l + p1,1,1,l − 2
p−1,−1,−1,l + 2p1,1,−1,l + p−1,−1,1,l + p−1,1,1,l − 2
p1,−1,−1,l + p1,1,−1,l + 2p−1,−1,1,l + p1,1,1,l − 2
p−1,−1,−1,l + p−1,1,−1,l + p−1,−1,1,l + 2p1,1,1,l − 2

,
U (l) = min

1− p1,−1,−1,l − p−1,1,1,l
1− p−1,1,−1,l − p1,−1,1,l
1− p−1,1,−1,l − p1,−1,−1,l
1− p−1,1,1,l − p1,−1,1,l
2− 2p−1,1,−1,l − p1,−1,−1,l − p1,−1,1,l − p1,1,1,l
2− p−1,1,−1,l − 2p1,−1,−1,l − p−1,−1,1,l − p−1,1,1,l
2− p1,−1,−1,l − p1,1,−1,l − 2p−1,1,1,l − p1,−1,1,l
2− p−1,−1,−1,l − p−1,1,−1,l − p−1,1,1,l − 2p1,−1,1,l

,
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L−1 (l) = max

p1,−1,1,l
p1,−1,−1,l
p1,−1,−1,l + p1,1,−1,l − p−1,−1,1,l − p1,1,1,l
p−1,1,−1,l + p1,−1,−1,l − p−1,−1,1,l − p−1,1,1,l
 ,
U−1 (l) = min

1− p−1,−1,1,l
1− p−1,−1,−1,l
p−1,1,−1,l + p1,−1,−1,l + p1,−1,1,l + p1,1,1,l
p1,−1,−1,l + p1,1,−1,l + p−1,1,1,l + p1,−1,1,l
 ,
and py,a,z,l denotes Pr(Y = y, A = a|Z = z, L = l).
Proof. We consider construction of bounds for the value function with a valid
IV. Note that
E
(
YD(L)|L
)
= E (Y1 − Y−1|L) I {D(L) = 1}+ E (Y−1|L) .
By the results from Balke and Pearl (1997), one has the following
L (L) I {D(L) = 1}+L−1 (L) ≤ E
(
YD(L)|L
) ≤ U (L) I {D(L) = 1}+U−1 (L) ,
where L (L) and U (L) are lower and upper bounds for E (Y1 − Y−1|L) given
by Balke and Pearl (1997), while L−1 (L) and U−1 (L) are lower and upper
bounds for E (Y−1|L) obtained by Balke and Pearl (1997). Therefore, we
have that
E [L (L) I {D(L) = 1}] + E [L−1 (L)] ≤ E
(
YD(L)
)
,
E [U (L) I {D(L) = 1}] + E [U−1 (L)] ≥ E
(
YD(L)
)
.
Therefore, E
(
YD(L)
)
is lower bounded by E [L (L) I {D(L) = 1}] plus
a constant which does not depend on D. Following the same argument,
E
(
YD(L)
)
is also lower bounded by E [−U (L) I {D(L) = −1}] up to a con-
stant not depending on D. Because it is not possible to directly maximize
the value function, one may nevertheless proceed by maximizing its lower
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bound. For instance, if A = −1 refers to placebo, the safest regime might
be maximizing E [L (L) I {D(L) = 1}], i.e., assigning only A = 1 to those for
whom L(L) > 0. Note that there are infinitely many lower bounds, and max-
imizing the above two bounds separately would recommend two conflicting
treatments to patients whose interval (L(L),U(L)) covers 0, i.e., the treat-
ment decision remains ambiguous to these patients. We caution that the
interval estimate might not be further narrowed down to a simple decision
for whom (L(L),U(L)) covers 0 given the overwhelming uncertainty due to
potentially unmeasured confounding.
G Fisher consistency, excess risk bound and
universal consistency of the estimated regime
In this section, we establish Fisher consistency, excess risk bound and uni-
versal consistency of the estimated treatment regime. We focus on our first
estimator, however, the results hold for the second estimator.
G.1 Preliminaries
Define the following risk
R(g) ≡ E[WI{A 6= sign(g(L))}],
where W = AZY/(δ(L)f(Z|L)). The optimal decision function associated
with the optimal treatment regime D∗ is defined as g∗ ≡ arg ming∈G R(g) and
corresponding Bayes risk is R∗ ≡ R(g∗), where G is the class of all measurable
functions.
We also define the φ-risk
Rφ(g) ≡ E[|W |φ(sign(W )Ag(L))],
where φ is the hinge loss function. The minimal φ-risk R∗φ ≡ infg∈G Rφ(g)
and g∗φ ≡ arg ming∈G Rφ(g).
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G.2 Fisher consistency and excess risk bound
Note that Theorem 2.1 of Zhou and Kosorok (2017) shows that Fisher con-
sistency holds if and only if φ′(0) exists and φ′(0) < 0 provided that the loss
function φ is convex. The hinge loss function φ satisfies this condition which
essentially implies the following Fisher consistency.
Lemma G.1. Under Assumptions 2-7, R∗ = R(g∗φ).
The following theorem states that for any measurable decision function
g, the excess risk under 0-1 loss is bounded by the excess φ-risk.
Lemma G.2. Under Assumptions 2-7, for any measurable decision function
g, we have that
R(g)−R∗ ≤ Rφ(g)−R∗φ.
The proof follows from Theorem 2.2 of Zhou and Kosorok (2017). Lemma G.2
implies that the loss of the value function due to the individualized treat-
ment regime D associated with the decision function g can be bounded by
the excess risk under the hinge loss. This excess bound also serves as an
intermediate step for investigating the universal consistency of the estimated
treatment regime.
G.3 Consistency of the estimated treatment regime
In this section, we establish the universal consistency of the estimated treat-
ment regime with a universal kernel (e.g., Gaussian kernel). Estimation error
has two potential sources. The first is from the approximation error associ-
ated with HK . The second is the uncertainty in estimated weights.
Before stating the universal consistency result of the estimated treatment
regime, we first introduce the concept of universal kernels (Steinwart and
Christmann, 2008). A continuous kernel K on a compact metric space L is
called universal if its associated reproducing kernel Hilbert space (RKHS)
HK is dense in C(L), where C(L) is the space of all continuous functions on
the compact metric space L endowed with the usual supremum norm.
36
Let K be a universal kernel, and HK be the associated RKHS. Suppose
that g∗φ is measurable and bounded, |g∗φ| ≤ Mg, and |
√
λnbn| ≤ Mb almost
surely for some constant Mg and Mb. In addition, we consider a sequence of
tuning parameters λn → 0 and nλn → ∞ as n → ∞. In order to study the
excess risk bound of the φ loss, we need one additional assumption to bound
the weight W .
Assumption 11. The outcome Y is sub-Gaussian. Furthermore, we assume
that |δ(L)| > M for some M > 0 almost surely.
Then, we have the following result.
Theorem G.1. Under Assumptions 2-7, 11, and further assume that
sup
l∈L
|δ̂(l)− δ(l)| p→ 0, and sup
l∈L
|f̂(z = 1|l)− f(z = 1|l)| p→ 0,
as n→∞, we have the following convergence in probability,
lim
n→∞
R(gn) = R
∗,
where gn = hn + bn is the estimated decision function from
min
g=h+b∈HK+{1}
1
n
n∑
i=1
|ŵi|φ(sign(ŵi)aig(li)) + λ
2
||h||2K .
The proof is akin to Zhao et al. (2012); Zhou and Kosorok (2017). The
rate of convergence for the estimated treatment regime might also be studied
under certain regularity conditions on the distribution of the data, such as
the geometric noise assumption proposed by Steinwart and Scovel (2007).
H A locally efficient and multiply robust es-
timation of value function
Consider the nonparametric model Mnp which places no restriction on the
observed data law. Below, we characterize the efficient influence function of
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the value functional V(D) in Mnp and therefore characterize the semipara-
metric efficiency bound for the model, where functional V(D) is defined in
Equation (5).
Theorem H.1. Under Assumptions 2-6 and 8, the efficient influence func-
tion of V(D) in Mnp is given by
EIFV(D) =
ZAY I{A = D(L)}
f(Z|L)δ(L) −
{
ZE[AY I{A = D(L)}|Z,L]
f(Z|L)δ(L)
−
∑
z
zE[AY I{A = D(L)}|Z = z, L]
δ(L)
+
Z[A− E(A|Z,L)]
2f(Z|L)δ(L)
∑
z
E[AY I{A = D(L)}|Z = z, L]z
δ(L)
}
− V(D).
Therefore, the semiparametric efficiency bound of V(D) inMnp equals E[EIF 2V(D)].
One cannot be confident that any of the required nuisance models to
evaluate the efficient influence function can be correctly specified. It is of in-
terest to develop a multiply robust estimation approach, which is guaranteed
to deliver valid inferences about V(D) provided that some but not necessar-
ily all needed models are correct. When finite-dimensional models are used
for nuisance parameters, it is likely that all of them are misspecified leading
to lack of consistency. Using infinite-dimensional models can mitigate the
problem, however, to achieve asymptotic linearity it is required that all the
parts are consistently estimated with sufficiently fast rates (Robins et al.,
2017; Chernozhukov et al., 2018).
In order to describe our proposed multiply robust approach, consider the
following three semiparametric models that place restrictions on different
components of the observed data likelihood while allowing the rest of the
likelihood to remain unrestricted.
M1: models for f(Z|L) and δ(L) are correct;
M2: models for f(Z|L) and γ(L) ≡
∑
z{zE[AY I{A = D(L)}|Z = z, L]}/δ(L)
are correct;
M3: models for γ(L), γ′(L) ≡ E[AY I{A = D(L)}|Z = −1, L], δ(L) and
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E[A|Z = −1, L] are correct.
Note that by Theorem K.1 presented in Section K, γ(L) has the coun-
terfactual interpretation E[YD(L)|L], which may help formulate appropriate
parametric models for the former. For instance, in case Y is binary, γ(L)
would need to be specified with appropriate link function to ensure it falls
within the unit interval (0, 1).
Our proposed multiply robust estimator requires estimation of nuisance
parameters f(Z|L), E(A|Z = −1, L), γ′(L), δ(L) and γ(L). One may use
maximum likelihood estimation for f(Z|L), E(A|Z = −1, L), γ′(L), denoted
as f̂(Z|L), Ê(A|Z = −1, L) and γ̂′(L), respectively.
Because δ(L) and γ(L) are shared across submodels of the union model,
i.e.,M1∪M3,M2∪M3, respectively, in order to ensure multiple robustness,
one must estimate these unknown functions in their respective union model.
For estimating δ(L), we propose to use doubly robust g-estimation (Robins,
1994, 2000),
Pnψ1(L)
[
A− δ(L, β̂)1 + Z
2
− Ê(A|Z = −1, L)
]
Z
f̂(Z|L)
= 0,
and we propose the following doubly robust estimating equation to estimate
γ(L),
Pnψ2(L)
[
AY I{A = D(L)} − γ̂′(L)− [A− Ê(A|Z = −1, L)]γ(L, η̂)
2
]
Z
f̂(Z|L)
= 0,
where vector-valued functions ψ1(L) and ψ2(L) have the same dimension as β̂
and η̂, respectively. Thus, δ(L, β̂) is consistent and asymptotically normal in
the union modelM1∪M3, and γ(L, η̂) is consistent and asymptotically nor-
mal in the union modelM2∪M3. Similarly to results in Tchetgen Tchetgen
et al. (2018), we have the following theorem.
Theorem H.2. Under Assumptions 2-6, 8 and standard regularity condi-
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tions,
V̂MR(D) =Pn
[
ZAY I{A = D(L)}
f̂(Z|L)δ(L, β̂)
− Zγ̂
′(L)
f̂(Z|L)δ(L, β̂)
+ γ(L, η̂)− Z[A− Ê(A|Z = −1, L)]
2f̂(Z|L)δ(L, β̂)
γ(L, η̂)
]
(13)
is a consistent and asymptotically normal estimator of V(D) under the semi-
parametric union model Munion = M1 ∪M2 ∪M3. Furthermore, V̂MR(D)
is semiparametric locally efficient in Munion at the intersection submodel
Mint =M1 ∩M2 ∩M3.
Based on Theorem H.2, one may evaluate the value function E[YD(L)]
for any given treatment regime D with multiple robustness property. We
derive the influence function of V̂MR(D) in Section J, which can be used to
nonparametrically estimate the standard deviation of value function under a
given regime.
I Proof of Theorem H.1
Proof. In order to find the efficient influence function for V(D), we need to
find the canonical gradient G for V(D) in the nonparametric model Mnp,
e.g, find a random variable G with mean 0 and
∂
∂t
Vt(D)
∣∣
t=0
= E[GS(O; t)]∣∣
t=0
,
where S(O; t) = ∂ log f(O; t)/∂t, and Vt(D) is the value function under a
regular parametric submodel in Mnp indexed by t that includes the true
data generating mechanism at t = 0 (Van der Vaart, 1998). Note that we
have
∂
∂t
Vt(D)
∣∣
t=0
=E[
ZAY I(A = D(L))
δ(L)f(Z|L) S(O)]− E
[
ZAY I(A = D(L))
δ2(L)f 2(Z|L) [
∂
∂t
ft(Z|L)δ(L) + ∂
∂t
δt(L)f(Z|L)]
]∣∣∣∣
t=0
=(I)− (II)− (III).
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The second term
(II) =E
[
ZAY I(A = D(L))
δ2(L)f2(Z|L)
∂
∂t
ft(Z|L)δ(L)
]∣∣∣∣
t=0
=E
[
ZAY I(A = D(L))
δ(L)f(Z|L) S(Z|L)
]
=E
[
E[
ZAY I(A = D(L))
δ(L)f(Z|L) |Z,L]S(Z|L)
]
=E
[{
E[
ZAY I(A = D(L))
δ(L)f(Z|L) |Z,L]− E[
∑
z
zAY I(A = D(L))
δ(L)
|Z = z, L]
}
S(Z|L)
]
=E
[{
E[
ZAY I(A = D(L))
δ(L)f(Z|L) |Z,L]− E[
∑
z
zAY I(A = D(L))
δ(L)
|Z = z, L]
}
S(Z,L)
]
=E
[{
E[
ZAY I(A = D(L))
δ(L)f(Z|L) |Z,L]− E[
∑
z
zAY I(A = D(L))
δ(L)
|Z = z, L]
}
S(O)
]
=E
[{ZE[AY I(A = D(L))|Z,L]
δ(L)f(Z|L) −
∑
z
zE[AY I(A = D(L))|Z = z, L]
δ(L)
}
S(O)
]
.
In order to calculate (III), we need to calculate the term ∂
∂t
δt(L). To do
so, we first calculate ∂
∂t
Et[A|Z = z, L]
∣∣
t=0
.
∂
∂t
Et[A|Z = z, L]
=
∂
∂t
∫
aft(a|Z = z, L)da
=
∫
a
∂ft(a|Z = z, L)
ft(a|Z = z, L) ft(a|Z = z, L)da
=E[A
∂ft(A|Z = z, L)
ft(A|Z = z, L) |Z = z, L],
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and
∂
∂t
Et[A|Z = z, L]
∣∣∣∣
t=0
=E[AS(A|Z = z, L)|Z = z, L]
=E[(A− E[A|Z = z, L])S(A|Z = z, L)|Z = z, L]
=E[(A− E[A|Z = z, L])S(A,Z = z|L)|Z = z, L].
Then
2
∂
∂t
δt(L)
∣∣∣∣
t=0
=E[(A− E[A|Z = 1, L])S(A,Z = 1|L)|L]− E[(A− E[A|Z = −1, L])S(A,Z = −1|L)|L]
=E[
Z
f(Z|L)(A− E[A|Z,L])S(A,Z|L)|L]
=E[
Z
f(Z|L)(A− E[A|Z,L])S(A,Z|L)|L] + E[
Z
f(Z|L)(A− E[A|Z,L])S(L)|L]
=E[
Z
f(Z|L)(A− E[A|Z,L])S(A,Z, L)|L]
=E[
Z
f(Z|L)(A− E[A|Z,L])S(A,Z, L)|L] + E[
Z
f(Z|L)(A− E[A|Z,L])S(Y |A,Z, L)|L]
=E[
Z
f(Z|L)(A− E[A|Z,L])S(A, Y, Z, L)|L].
It follows that
(III) =E
[
ZAY I(A = D(L))
δ2(L)f 2(Z|L)
∂
∂t
δt(L)f(Z|L)
]∣∣∣∣
t=0
=
1
2
E
[
E[
ZAY I(A = D(L))
δ2(L)f(Z|L) |L]E[
Z
f(Z|L)(A− E[A|Z,L])S(O)|L]
]
=
1
2
E
[∑
z
zE[AY I(A = D(L))|Z = z, L]
δ2(L)
E[
Z
f(Z|L)(A− E[A|Z,L])S(O)|L]
]
=
1
2
E
[∑
z
zE[AY I(A = D(L))|Z = z, L]
δ2(L)
Z
f(Z|L)(A− E[A|Z,L])S(O)
]
.
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Thus, ∂
∂t
Vt(D)|t=0 further equals to
E[
ZAY I(A = D(L))
δ(L)f(Z|L) S(O)]
− E
[{ZE[AY I(A = D(L))|Z,L]
δ(L)f(Z|L) −
∑
z
zE[AY I(A = D(L))|Z = z, L]
δ(L)
}
S(O)
]
− 1
2
E
[∑
z
zE[AY I(A = D(L))|Z = z, L]
δ2(L)
Z
f(Z|L)(A− E[A|Z,L])S(O)
]
.
So the canonical gradient in Mnp is
ZAY I(A = D(L))
f(Z|L)δ(L) −
{
ZE[AY I(A = D(L))|Z,L]
f(Z|L)δ(L)
−
∑
z
zE[AY I(A = D(L))|Z = z, L]
δ(L)
+
Z(A− E(A|Z,L))
2f(Z|L)δ(L)
∑
z
E[AY I(A = D(L))|Z = z, L]z
δ(L)
}
− V(D).
As shown by Bickel et al. (1993); Newey (1990); Van der Vaart (1998), the
canonical gradient inMnp equals to the efficient influence function evaluated
at observed data O, which completes our proof.
J Proof of Theorem H.2
Proof. We start from multiply robustness. Under some regularity condi-
tions (White, 1982), the nuisance estimators δ(L, β̂), γ(L, η̂), γ̂′(L), f̂(Z|L),
Ê(A|Z = −1, L), converge in probability to δ(L, β∗), γ(L, η∗), γ∗′(L), f ∗(Z|L),
E∗(A|Z = −1, L). It suffices to show that in the union model Munion,
E
[
ZAY I(A = D(L))
f ∗(Z|L)δ(L, β∗) −
{
Zγ∗′(L)
f ∗(Z|L)δ(L, β∗) − γ(L, η
∗)
+
Z[A− E∗(A|Z = −1, L)]
2f ∗(Z|L)δ(L, β∗) γ(L, η
∗)
}]
= E[YD(L)].
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We first note that
E
[
ZAY I(A = D(L))
f ∗(Z|L)δ(L, β∗) −
{
Zγ∗′(L)
f ∗(Z|L)δ(L, β∗) − γ(L, η
∗) (14)
+
Z[A− E∗(A|Z = −1, L)]
2f ∗(Z|L)δ(L, β∗) γ(L, η
∗)
}]
=E
[
ZAY I(A = D(L))
f ∗(Z|L)δ(L, β∗) −
{
Z[γ(L, η∗)(1 + Z)δ(L, β∗) + 2γ∗′(L)]
2f ∗(Z|L)δ(L, β∗) − γ(L, η
∗)
+
Z[A− E∗(A|Z = −1, L)− (1 + Z)δ(L, β∗)]
2f ∗(Z|L)δ(L, β∗) γ(L, η
∗)
}]
(15)
If M1 is correctly specified, Equation (15) equals to
E
[
ZAY I(A = D(L))
f(Z|L)δ(L) −
Z[A− E∗(A|Z = −1, L)− (1 + Z)δ(L)]
2f(Z|L)δ(L) γ(L, η
∗)
]
=E
[
ZAY I(A = D(L))
f(Z|L)δ(L) −
Z(E[A|Z = −1, L]− E∗[A|Z = −1, L])
2f(Z|L)δ(L) γ(L, η
∗)
]
=E
[
E
[
ZAY I(A = D(L))
f(Z|L)δ(L) |L
]]
=E[YD(L)].
If M2 is correctly specified, Equation (15) equals to
E
[
ZAY I(A = D(L))
f(Z|L)δ(L, β∗) −
Z[A− E∗(A|Z = −1, L)− (1 + Z)δ(L, β∗)]
2f(Z|L)δ(L, β∗) γ(L)
]
=E
[∑
z
z
δ(L, β∗)
E[AY I(A = D(L))|Z = z, L]
− Z[A− E
∗(A|Z = −1, L)− (1 + Z)δ(L, β∗)]
2f(Z|L)δ(L, β∗) γ(L)
]
=E
[
δ(L)
δ(L, β∗)
γ(L)−
∑
z
z[δ(L)z − δ(L, β∗)z]
2δ(L, β∗)
γ(L)
]
=E[YD(L)].
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Finally, if M3 is correctly specified, notice that
E[AY I(A = D(L))|Z,L] = γ(L)δ(L)1 + Z
2
+ γ′(L),
so we have Equation (15) equals to
E
[
ZAY I(A = D(L))
f ∗(Z|L)δ(L) −
{
Z[γ(L)(1 + Z)δ(L) + 2γ′(L)]
2f ∗(Z|L)δ(L) − γ(L)
}]
=E
[
ZE[AY I(A = D(L))|Z,L]
f ∗(Z|L)δ(L) −
Z[γ(L)(1 + Z)δ(L) + 2γ′(L)]
2f ∗(Z|L)δ(L) + γ(L)
]
=E[YD(L)].
As shown by Robins and Rotnitzky (2011), the efficient influence func-
tion in Munion coincides with the efficient influence function in Mnp, i.e.,
EIFV(D). Thus, in order to show asymptotic normality and local efficiency,
we need to derive the influence function of V̂MR(D). Let η be a vector includ-
ing all nuisance parameters. From a standard Taylor expansion of EIFV(D)
around V(D) and η, following uniform weak law of large number (Newey and
McFadden, 1994) under some regularity conditions, we have
√
n(V̂MR(D)− V(D)) = 1√
n
n∑
i=1
EIFV(D)(Oi) + E(
∂EIFV(D)
∂η
)
√
n(η̂ − η) + op(1).
Following from the proof of multiple robustness, we have E(∂EIFV(D)/∂η) =
0 under the intersection model Mint. This completes our proof.
K Theorem K.1 and its proof
Theorem K.1. Under Assumptions 2-6 and 8, we have that
γ(L) = E[YD(L)|L].
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Proof. Note that
γ(L) =
∑
z
zE[AY I(A = D(L))|Z = z, L]
δ(L)
=
E[AY I(A = D(L))|Z = 1, L]
δ(L)
− E[AY I(A = D(L))|Z = −1, L]
δ(L)
=
∑
a
E[aYaI(A = D(L))I(A = a)|Z = 1, L]
δ(L)
−
∑
a
E[aYaI(A = D(L))I(A = a)|Z = −1, L]
δ(L)
=
∑
a
E
[
aE[Ya|L,U ]I(D(L) = a) Pr(A = a|Z = 1, L, U)
]
δ(L)
−
∑
a
E
[
aE[Ya|L,U ]I(D(L) = a) Pr(A = a|Z = −1, L, U)
]
δ(L)
=
E
[
E[Y1|L,U ]I(D(L) = 1) Pr(A = 1|Z = 1, L, U)
]
δ(L)
− E
[
E[Y−1|L,U ]I(D(L) = −1) Pr(A = −1|Z = 1, L, U)
]
δ(L)
− E
[
E[Y1|L,U ]I(D(L) = 1) Pr(A = 1|Z = −1, L, U)
]
δ(L)
+
E
[
E[Y−1|L,U ]I(D(L) = −1) Pr(A = −1|Z = −1, L, U)
]
δ(L)
=E[Y1|L]I(D(L) = 1) + E[Y−1|L]I(D(L) = −1)
=E[YD(L)|L].
L Additional simulations
L.1 Sensitivity analysis on the strength of the IV
In this section, we conducted the sensitivity analysis on the strength of the
IV. Treatment A was generated under a logistic regression with success prob-
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ability,
Pr(A = 1|Z,L, U) = expit{2L(1) + 3Z − 0.5U},
and
Pr(A = 1|Z,L, U) = expit{2L(1) + 2Z − 0.5U},
respectively, with Z Bernoulli event with probability 1/2, and U from a bridge
distribution with parameter φ = 1/2. The mean compliance rate are about
0.74 and 0.54 for two scenarios, respectively. The mean compliance rate is
about 0.66 for the scenario considered in the article. Table 4 and 6 report
the mean and standard deviation of value functions evaluated at estimated
optimal regimes in test samples for two scenarios, respectively. Table 5 and 7
report the mean and standard deviation of correct classification rates in test
samples for two scenarios, respectively. As can be seen from tables, higher
compliance rate generally leads to a lower variance of the estimated regime
in terms of both value functions and correct classification rates.
Table 4: Simulation results: Mean ×10−2 (sd ×10−2) of value functions
Kernel OWL RWL IV-IW IV-MR
1
Linear 94.5 (4.7) 96.5 (2.9) 96.6 (3.7) 97.6 (2.1)
Gaussian 87.7 (7.0) 95.0 (2.9) 90.8 (8.2) 94.6 (4.8)
2
Linear 38.1 (18.9) 40.1 (19.3) 93.0 (6.6) 93.8 (6.0)
Gaussian 64.1 (9.0) 65.0 (9.2) 84.3 (10.4) 87.7 (9.1)
3
Linear 354.0 (6.1) 358.6 (3.0) 359.5 (2.7) 359.6 (2.2)
Gaussian 302.9 (33.3) 356.4 (4.1) 320.9 (33.0) 357.0 (5.8)
4
Linear 275.4 (5.4) 275.5 (5.3) 351.6 (8.4) 351.7 (8.2)
Gaussian 282.4 (14.2) 302.4 (14.6) 314.0 (32.9) 337.8 (19.1)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR; The empirical opti-
mal value functions are 0.998, 0.995, 3.636, 3.630 for four scenarios, respec-
tively.
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Table 5: Simulation results: Mean ×10−2 (sd ×10−2) of correct classification
rates
Kernel OWL RWL IV-IW IV-MR
1
Linear 86.1 (5.6) 89.0 (4.1) 89.3 (4.7) 91.0 (3.3)
Gaussian 79.2 (6.8) 86.9 (3.9) 83.0 (8.1) 86.9 (5.4)
2
Linear 43.3 (11.0) 44.2 (10.9) 84.9 (7.2) 85.8 (6.7)
Gaussian 59.4 (6.2) 60.3 (6.6) 76.7 (9.2) 79.8 (8.2)
3
Linear 86.9 (4.4) 89.1 (4.0) 91.3 (3.0) 90.6 (2.9)
Gaussian 72.4 (9.4) 87.6 (4.3) 77.8 (11.2) 89.3 (4.2)
4
Linear 37.3 (2.2) 37.4 (2.3) 84.5 (5.9) 84.3 (6.1)
Gaussian 47.6 (7.1) 51.0 (8.3) 71.0 (11.2) 77.5 (9.5)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR.
Table 6: Simulation results: Mean ×10−2 (sd ×10−2) of value functions
Kernel OWL RWL IV-IW IV-MR
1
Linear 96.8 (1.9) 97.7 (1.4) 93.7 (6.5) 95.3 (4.9)
Gaussian 87.9 (8.2) 96.0 (2.7) 86.3 (10.6) 90.5 (8.0)
2
Linear 35.0 (17.1) 38.3 (18.7) 88.8 (8.9) 89.5 (9.0)
Gaussian 59.0 (10.1) 58.8 (11.1) 77.6 (12.6) 81.1 (11.4)
3
Linear 358.0 (3.6) 360.2 (2.1) 356.8 (5.4) 357.4 (4.2)
Gaussian 288.3 (33.5) 357.5 (4.5) 305.7 (34.6) 350.9 (13.0)
4
Linear 274.6 (0.0) 275.0 (3.6) 343.5 (20.0) 345.1 (16.9)
Gaussian 279.0 (11.2) 293.5 (13.2) 297.9 (32.2) 320.0 (25.1)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR; The empirical opti-
mal value functions are 0.998, 0.995, 3.636, 3.630 for four scenarios, respec-
tively.
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Table 7: Simulation results: Mean ×10−2 (sd ×10−2) of correct classification
rates
Kernel OWL RWL IV-IW IV-MR
1
Linear 89.4 (3.4) 91.1 (3.0) 85.3 (7.0) 87.3 (5.6)
Gaussian 79.8 (8.0) 88.4 (3.8) 78.5 (9.4) 82.5 (7.6)
2
Linear 41.4 (9.7) 43.0 (10.2) 80.2 (8.7) 80.9 (8.8)
Gaussian 55.3 (6.4) 55.5 (7.2) 71.1 (10.1) 73.8 (9.5)
3
Linear 90.0 (3.3) 91.0 (3.3) 88.9 (4.1) 88.7 (3.6)
Gaussian 69.2 (10.4) 88.9 (4.6) 71.6 (11.8) 85.9 (6.5)
4
Linear 37.0 (0.0) 37.2 (1.5) 80.4 (9.7) 80.8 (8.9)
Gaussian 42.8 (5.4) 45.4 (6.5) 65.5 (10.7) 70.7 (10.0)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR.
L.2 Additional simulations with different sample sizes
Tables 8-9 and 10-11 report the simulation results with sample size 250 and
1000, respectively.
Table 8: Simulation results: Mean ×10−2 (sd ×10−2) of value functions
(sample size n = 250)
Kernel OWL RWL IV-IW IV-MR
1
Linear 92.0 (6.5) 95.5 (3.2) 93.0 (6.2) 94.3 (5.4)
Gaussian 82.7 (8.7) 92.8 (4.8) 81.5 (11.4) 87.9 (9.8)
2
Linear 48.5 (22.7) 51.7 (22.3) 87.0 (9.6) 87.4 (9.5)
Gaussian 61.6 (11.1) 62.0 (12.9) 75.7 (12.1) 77.4 (12.3)
3
Linear 349.5 (11.8) 357.4 (4.0) 354.7 (8.4) 355.9 (5.5)
Gaussian 282.7 (35.4) 354.0 (6.4) 298.7 (35.7) 346.1 (17.2)
4
Linear 278.5 (12.7) 280.8 (15.1) 339.7 (21.1) 340.3 (19.3)
Gaussian 276.5 (17.7) 299.3 (15.4) 295.6 (33.7) 317.8 (25.3)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR; The empirical opti-
mal value functions are 0.998, 0.995, 3.636, 3.630 for four scenarios, respec-
tively.
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Table 9: Simulation results: Mean ×10−2 (sd ×10−2) of correct classification
rates (sample size n = 250)
Kernel OWL RWL IV-IW IV-MR
1
Linear 83.2 (7.0) 87.4 (4.6) 84.3 (6.7) 86.0 (6.1)
Gaussian 74.5 (8.1) 84.4 (5.4) 74.2 (9.8) 80.1 (8.9)
2
Linear 50.0 (14.1) 51.3 (13.4) 78.3 (8.8) 78.7 (8.7)
Gaussian 58.0 (7.4) 58.5 (8.6) 69.4 (9.6) 70.7 (9.8)
3
Linear 84.8 (5.3) 88.2 (4.3) 87.6 (5.0) 87.6 (4.5)
Gaussian 67.3 (9.8) 85.8 (5.5) 70.2 (11.9) 83.3 (8.4)
4
Linear 39.0 (6.2) 39.9 (7.2) 78.7 (9.6) 78.6 (9.4)
Gaussian 46.6 (6.9) 49.9 (8.6) 65.1 (10.8) 69.8 (10.6)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR.
Table 10: Simulation results: Mean ×10−2 (sd ×10−2) of value functions
(sample size n = 1000)
Kernel OWL RWL IV-IW IV-MR
1
Linear 97.7 (1.4) 98.4 (0.9) 97.6 (2.2) 98.2 (1.1)
Gaussian 91.4 (6.0) 97.2 (1.6) 93.4 (5.3) 96.1 (2.6)
2
Linear 29.1 (8.6) 31.9 (12.8) 95.0 (5.2) 95.7 (4.5)
Gaussian 62.5 (6.6) 62.1 (7.3) 88.7 (8.1) 90.8 (6.1)
3
Linear 359.4 (2.5) 360.8 (1.5) 360.4 (1.9) 360.1 (1.7)
Gaussian 305.2 (29.8) 359.2 (2.8) 331.8 (29.7) 359.0 (3.8)
4
Linear 274.6 (0.0) 274.7 (1.3) 355.1 (4.2) 354.7 (3.9)
Gaussian 283.3 (10.4) 299.0 (11.5) 325.9 (29.2) 345.8 (13.1)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR; The empirical opti-
mal value functions are 0.998, 0.995, 3.636, 3.630 for four scenarios, respec-
tively.
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Table 11: Simulation results: Mean ×10−2 (sd ×10−2) of correct classifica-
tion rates (sample size n = 1000)
Kernel OWL RWL IV-IW IV-MR
1
Linear 91.0 (2.9) 92.8 (2.4) 90.9 (3.4) 92.2 (2.6)
Gaussian 83.4 (6.3) 90.3 (2.8) 85.7 (5.5) 88.8 (3.5)
2
Linear 38.0 (4.5) 39.4 (6.5) 87.4 (5.9) 88.3 (5.3)
Gaussian 57.6 (4.8) 57.5 (5.4) 80.8 (7.4) 82.6 (6.1)
3
Linear 91.3 (2.8) 91.5 (2.7) 92.2 (2.5) 91.2 (2.4)
Gaussian 73.8 (9.2) 90.7 (3.3) 81.2 (10.5) 91.3 (3.0)
4
Linear 37.0 (0.0) 37.1 (0.7) 87.0 (3.9) 86.5 (3.7)
Gaussian 44.1 (5.4) 47.9 (6.3) 75.4 (10.7) 81.5 (7.1)
OWL: outcome weighted learning; RWL: residual weighted learning; IV-IW:
the proposed estimators with weights W (1) or W (2); IV-MR: the proposed
multiply robust estimators with weights W
(1)
MR or W
(2)
MR.
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